ORAMED PHARMACEUTICALS INC. Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31)
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ORAMED PHARMACEUTICALS INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for the quarter ending 2014-08-31 was -$85.00.
- ORAMED PHARMACEUTICALS INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for the quarter ending 2014-05-31 was $0.00.
- ORAMED PHARMACEUTICALS INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for fiscal 2014 was $14.89M, a 251.19% increase from fiscal 2013.
- ORAMED PHARMACEUTICALS INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for fiscal 2013 was $4.24M.
| Period end | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 3 month | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 12 month |
|---|---|---|
| 2014-08-31 | -$85.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-14 | $14.89M 10-K · filed 2014-11-14 |
| 2014-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-14 | |
| 2013-08-31 | $4.24M 10-K · filed 2014-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |